Remove FDA Remove Health Outcomes Remove Medicaid
article thumbnail

Healthcare Decisions at an Organizational Level – 2025 Health IT Predictions

Healthcare IT Today

This shift, driven by the FDA’s Diversity Action Plans, will accelerate trial enrollment, improve representation, and ultimately enhance patient safety by ensuring more diverse data in research. These networks ensure employees can receive top-tier care regardless of location, enhancing satisfaction and improving health outcomes.

article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

The platform has embedded video conferencing, or works alongside the video conferencing platform a health system has in place. It also equips providers with Eko’s FDA-cleared AI to assist in remote screening for AFib, heart murmurs, tachycardia and bradycardia. iRhythm Technologies.

COVID-19 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now

Health Law Advisor

In 2021, the FDA approved the first anti-amyloid monoclonal antibody drug, Aduhelm, which is intended to trigger a response by the patient’s own immune system that destroys the accumulation of amyloid plaques. The FDA’s determination does not mandate Medicare coverage for Aduhelm. What Happens Next?

article thumbnail

15 HLTH 2021 Predictions from Digital Health Executives to Watch

HIT Consultant

COVID was a wakeup call: state public health departments were unable to process test results quickly because of lack of a standard way for labs to report test results, slowing the pandemic response. So, high quality, accurate data will be an imperative for member satisfaction. via a mobile app.

article thumbnail

The healthcare executive’s guide to AI

Redox

These enhancements have the potential to not only reduce provider costs, but also prevent errors, advance treatments, and improve health outcomes. AI’s superpower lies in its ability to intelligently mine insights from the exponential amount of health data that is generated every second.

FDA 69
article thumbnail

Using Machine Learning in the Evolving Landscape of Real-World Data

HIT Consultant

In fact, in January 2021, the FDA released an Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan, a clear indication of the technology’s explosive growth and legitimacy within healthcare. Zeynep Icten, Ph.D., Director of Data Science Solutions at Panalgo.

FDA 52
article thumbnail

Health Provider News

Hall Render

CT’s Medicaid reimbursement rates lower than peer states: report Better safety training, reporting, escorts for CT home health care workers focus of new legislation D.C. biotech pins hopes on 3 drug approvals as battles with FDA continue Luxury senior living facility coming to D.C. What they say sets them apart.